Skip to main content

US ClosedU.S. Closed

BCRX: BioCryst Pharmaceuticals, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

BioCryst Pharmaceuticals, Inc. is a biotechnology company focused on discovering and developing novel, orally administered, small-molecule therapeutics.

52W Range

73rdpctl

Volume

0.60×avg

Market Cap

2.50BUSD

P/E Ratio

-6.8TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

BioCryst Pharmaceuticals, Inc.

BCRXNASDAQ Global Select·USD·Closed

BioCryst Pharmaceuticals, Inc.

BCRXNASDAQ·USD·Closed

$9.82

−0.51%

$9.82

−$0.05 (0.51%)

52W Range

73rdpctl

Volume

0.60×avg

Mkt Cap

2.50BUSD

P/E

-6.8TTM

Div Yield

–ann